Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Teitelbaum

Plastic Surgery Santa Monica, CA Medical Doctor

NPI 1356471882 CMS profile 16864

1301 20Th St, Suite 350, Santa Monica, CA 90404

Open in the dashboard

General payments

$62,461

195 records reported · program years 2019–2025

Research payments

$8,425

Paid to them · 13 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Steven Teitelbaum of Santa Monica, CA is reported in the CMS Open Payments database as having received $62,461 across 195 general payments and $8,425 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,949 30
2025 Research $1,350 4
2024 General $1,038 21
2024 Research $7,075 9
2023 General $1,126 13
2022 General $2,256 32
2021 General $1,625 36
2020 General $281 16
2019 General $46,187 47

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Teitelbaum
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Steven Teitelbaum were reported at $9,949. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Steven Teitelbaum Plastic Surgery median Middle half National median
2019 $46,187 $371 $122–$1,483 $163
2020 $281 $158 $52–$438 $114
2021 $1,625 $249 $87–$752 $132
2022 $2,256 $274 $102–$793 $149
2023 $1,126 $299 $113–$891 $160
2024 $1,038 $361 $124–$1,062 $164
2025 $9,949 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $47,717 88 payments
  2. Motiva USA, LLC $9,602 15 payments
  3. AbbVie, Inc. $1,944 39 payments
  4. Sientra, Inc. $1,309 19 payments
  5. Davol Inc. $631 10 payments
  6. Tepha Inc $397 8 payments
  7. Bard Peripheral Vascular, Inc. $322 8 payments
  8. Surgical Innovation Associates, Inc. $318 1 payment
  9. Integra LifeSciences Corporation $113 3 payments
  10. Vertex Pharmaceuticals Incorporated $62 2 payments
  11. Other $47 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $47,919 18 payments
  2. Food and Beverage $6,847 170 payments
  3. Travel and Lodging $6,264 4 payments
  4. Gift $1,114 2 payments
  5. Long term medical supply or device loan $318 1 payment
Products named General payments · program years 2019–2025
  1. NATRELLE $30,531 39 payments
  2. ALLODERM $15,084 9 payments
  3. Motiva Implant Matrix $9,180 11 payments
  4. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $2,102 40 payments
  5. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $1,801 32 payments
  6. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $1,309 19 payments
  7. REVOLVE $1,080 1 payment
  8. Motiva SmoothSilk Round Breast Implant $422 4 payments
  9. GalaFLEX $397 8 payments
  10. Phasix Mesh $344 3 payments
  11. Other $1,199 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Motiva USA, LLC $8,425 13 payments

Records

208 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record